Hospital-acquired hyperkalaemia.
Bacon
N C
NC
Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, UK.
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects*; D001241:Aspirin / Q000009:adverse effects; D001262:Atenolol / Q000009:adverse effects; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced*; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged
D000319:Adrenergic beta-Antagonists; D000894:Anti-Inflammatory Agents, Non-Steroidal; D000925:Anticoagulants; D001262:Atenolol; D006493:Heparin; D001241:Aspirin